Bret Wacker
Impact in
- Genetics top 1%
- Chronic Lymphocytic Leukemia Research
- Dermatology top 5%
- Chemotherapy-related skin toxicity
Papers in
-
- Lung Cancer Treatments and Mutations 7
-
- Chemotherapy-related skin toxicity 2
- Co-authors
- Pedro Santabarbara (2 shared papers)Lee R. Brettman (2 shared papers)Michael J. Keating (1 shared paper)Peter Hillmen (1 shared paper)John C. Byrd (1 shared paper)Vinay Kumar Jain (1 shared paper)Jacques‐Louis Binet (1 shared paper)Ian W. Flinn (1 shared paper)
- Journals
- Journal of Clinical Oncology (3 papers)Journal of Thoracic Oncology (2 papers)Blood (1 paper)Clinical Cancer Research (1 paper)British Journal of Cancer (1 paper)
- Partner nations
- United StatesNetherlandsUnited Kingdom
In The Last Decade
Bret Wacker
9 papers receiving 1.5k citations
Peers
Comparison fields: 5 of 54
- Genetics 631
- Dermatology 126
- Oncology 179
- Pathology and Forensic Medicine 130
- Pulmonary and Respiratory Medicine 226
Countries citing papers authored by Bret Wacker
This map shows the geographic impact of Bret Wacker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bret Wacker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bret Wacker more than expected).
Fields of papers citing papers by Bret Wacker
This network shows the impact of papers produced by Bret Wacker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bret Wacker. The network helps show where Bret Wacker may publish in the future.
Co-authors
The 25 scholars most cited alongside Bret Wacker, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2002 | 776 | |
| 2 | 2007 | 326 | |
| 3 | 2002 | 257 | |
| 4 | 2011 | 73 | |
| 5 | The evaluation of E-Cadherin and vimentin as biomarkers of clinical outcomes among patients with non-small cell lung cancer treated with erlotinib as second- or third-line therapy. | 2012 | 47 |
| 6 | 2011 | 38 | |
| 7 | 2011 | 8 | |
| 8 | 2007 | 4 | |
| 9 | 2007 | 1 |
About Bret Wacker
Bret Wacker is a scholar working on Pulmonary and Respiratory Medicine, Dermatology, Genetics, Nuclear Energy and Engineering and Waste Management and Disposal, having authored 9 papers that have together received 1.5k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (7 papers), Chronic Lymphocytic Leukemia Research (2 papers) and Chemotherapy-related skin toxicity (2 papers). The work is most often cited by research in Genetics (631 citations), Dermatology (126 citations), Oncology (179 citations), Pathology and Forensic Medicine (130 citations) and Pulmonary and Respiratory Medicine (226 citations). Bret Wacker has collaborated with scholars based in United States, Netherlands and United Kingdom. Frequent co-authors include Pedro Santabarbara, Lee R. Brettman, Michael J. Keating, Peter Hillmen, John C. Byrd, Vinay Kumar Jain, Jacques‐Louis Binet, Ian W. Flinn, Maher X. Albitar and Pablo J. Cagnoni. Their work appears in journals such as Journal of Clinical Oncology, Journal of Thoracic Oncology, Blood, Clinical Cancer Research and British Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.